ClinicalTrials.Veeva

Menu

Transcranial Stimulation in Motor Stroke Rehabilitation

U

University of Turin

Status

Completed

Conditions

Stroke

Treatments

Device: Sham
Device: tDCS
Device: rTMS

Study type

Interventional

Funder types

Other

Identifiers

NCT02525393
CEI 339

Details and patient eligibility

About

Patients were randomized in 3 groups: two intervent groups and a control group. The first group received two weeks of daily session of repetitive Transcranial Magnetic Stimulation (rTMS, 10 sessions) and, at least 6 months after, two weeks of daily transcranial Direct Current Stimulation (tDCS, 10 sessions); the second group received 10 daily session of tDCS and, after at least 6 months, 10 sessions of rTMS; the control group received 10 daily session of sham tDCS.

Physiatric evaluations (ARAT scale), neuropsychological assessment and ERP (P300) were performed before (1 week) and after (1 week) the end of each treatment. Furthermore, all patients underwent follow-up neuropsychological assessment 6 months after the end of each stimulation period and follow-up physiatric evaluation at 3 and 6 months after the end of each stimulation period.

Enrollment

34 patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ischemic or hemorrhagic stroke (> 6 months from the accident)

Exclusion criteria

  • general cognitive impairment (Mini Mental State Examination < 25), severe functional disability (Barthel Index < 45),
  • psychiatric disorders,
  • degenerative neurological disorders,
  • epilepsy,
  • severe medical conditions,
  • having been implanted a drug infusion system, spinal/brain-stimulator, or endovascular coil

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

Triple Blind

34 participants in 3 patient groups

tDCS+rTMS
Experimental group
Description:
Stroke patients were treated with an initial two weeks of transcranial direct current stimulation and after six months with two weeks of repetitive transcranial magnetic stimulation.
Treatment:
Device: rTMS
Device: tDCS
rTMS+tDCS
Experimental group
Description:
Stroke patients were treated with an initial two weeks of repetitive transcranial magnetic stimulation and after six months with two weeks of transcranial direct current stimulation.
Treatment:
Device: rTMS
Device: tDCS
Sham stimulation
Sham Comparator group
Description:
Stroke patients were treated with two weeks of sham transcranial direct current stimulation.
Treatment:
Device: Sham

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems